Enanta Pharmaceuticals Statistics
Total Valuation
ENTA has a market cap or net worth of $118.40 million. The enterprise value is $141.16 million.
Important Dates
The last earnings date was Monday, May 12, 2025, after market close.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENTA has 21.33 million shares outstanding. The number of shares has increased by 0.70% in one year.
| Current Share Class | 21.33M |
| Shares Outstanding | 21.33M |
| Shares Change (YoY) | +0.70% |
| Shares Change (QoQ) | +0.55% |
| Owned by Insiders (%) | 6.71% |
| Owned by Institutions (%) | 70.09% |
| Float | 14.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| Forward PS | 2.53 |
| PB Ratio | 1.27 |
| P/TBV Ratio | 1.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.29, with a Debt / Equity ratio of 2.31.
| Current Ratio | 5.29 |
| Quick Ratio | 5.09 |
| Debt / Equity | 2.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.86 |
Financial Efficiency
Return on equity (ROE) is -74.26% and return on invested capital (ROIC) is -18.09%.
| Return on Equity (ROE) | -74.26% |
| Return on Assets (ROA) | -17.33% |
| Return on Invested Capital (ROIC) | -18.09% |
| Return on Capital Employed (ROCE) | -36.86% |
| Revenue Per Employee | $492,084 |
| Profits Per Employee | -$735,992 |
| Employee Count | 131 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.48M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.09% in the last 52 weeks. The beta is 0.82, so ENTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -56.09% |
| 50-Day Moving Average | 5.79 |
| 200-Day Moving Average | 8.62 |
| Relative Strength Index (RSI) | 51.09 |
| Average Volume (20 Days) | 178,500 |
Short Selling Information
The latest short interest is 2.96 million, so 13.86% of the outstanding shares have been sold short.
| Short Interest | 2.96M |
| Short Previous Month | 2.80M |
| Short % of Shares Out | 13.86% |
| Short % of Float | 20.69% |
| Short Ratio (days to cover) | 11.57 |
Income Statement
In the last 12 months, ENTA had revenue of $64.46 million and -$96.42 million in losses. Loss per share was -$4.54.
| Revenue | 64.46M |
| Gross Profit | 64.46M |
| Operating Income | -102.11M |
| Pretax Income | -118.12M |
| Net Income | -96.42M |
| EBITDA | -99.26M |
| EBIT | -102.11M |
| Loss Per Share | -$4.54 |
Full Income StatementBalance Sheet
The company has $193.38 million in cash and $216.14 million in debt, giving a net cash position of -$22.77 million or -$1.07 per share.
| Cash & Cash Equivalents | 193.38M |
| Total Debt | 216.14M |
| Net Cash | -22.77M |
| Net Cash Per Share | -$1.07 |
| Equity (Book Value) | 93.54M |
| Book Value Per Share | 4.38 |
| Working Capital | 196.91M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of -158.40% and -149.57%.
| Gross Margin | 100.00% |
| Operating Margin | -158.40% |
| Pretax Margin | -153.41% |
| Profit Margin | -149.57% |
| EBITDA Margin | -153.98% |
| EBIT Margin | -158.40% |
| FCF Margin | n/a |